Princess Margaret's Multidisciplinary Testicular Cancer (TCa) Clinic sees over 25% of Ontario's testicular cancer patients, many of whom travel long distances. Fortunately, the majority of cases are confined to the testicle and are managed by "active surveillance" (AS), whereby blood work and imaging at regular intervals look to detect relapse at a curable stage. This currently requires multiple clinic visits over 5-9 years. This follow-up can be time-consuming, costly, difficult to adhere to and unsatisfying for patients. The goal of this project is to develop an efficient technological platform to perform virtual cancer follow-up. The platform has been named, "WATChmAN" which stands for Web-based virtual Testicular CANcer clinic. It will provide a secure, online interface to all virtual follow-up visits as an alternative to costly and time-consuming travel for in-person visits. The investigators anticipate improved patient satisfaction and dramatic reductions in the cost of cancer care follow-up. Moreover, the investigators anticipate improved compliance, which will lead to safer care. While TCa serves as the working platform, the investigators envision the end-product to be scalable and generalizable to other cancers (e.g. prostate cancer surveillance) across the province.
No linked publications found in PubMed
Inclusion Criteria: * Men who are at least 18 years of age * Can read, write, and speak English * Have access to an electronic platform (i.e. computer, smart phone, tablet, etc.) * Have had histologically confirmed stage 1 testicular cancer (seminoma or non- seminoma), * Have undergone a radical orchiectomy in the last 9 months and will be/are on active surveillance under the supervision of the multidisciplinary testicular cancer clinic at Princess Margaret. * Must be prepared to comply with the close follow-up protocol and provide informed consent Exclusion Criteria: * Men who have experienced metastatic disease or TCa relapse within their first 9 months of AS * Men with inadequate computer literacy or compliance as deemed by the study team